When youre exhausted, sore, and emotionally raw, anything that promises a little relief feels worth trying
As reported by the American Journal of Managed Care, the approval of an oral semaglutide formulation marked the beginning of what many are calling the oral GLP-1 era. In December 2025, the FDA approved the Wegovy (semaglutide) tablet as the first once-daily oral GLP-1 receptor agonist indicated for chronic weight management in adults with obesity or overweight
Keep the morning fasted and delay carbohydrate intake until after any morning training if possible
The addition of DPP-4 inhibitors to patients already treated with metformin may seem particularly attractive, since both drugs may act to enhance circulating levels of GLP-1 and thus, may have synergistic effects on incretin receptor signaling [44,45,46]
Increased protein stability as a mechanism that enhances Nrf2-mediated transcriptional activation of the antioxidant response element